Suppr超能文献

2003 - 2015年埃塞俄比亚HIV感染成人中抗逆转录病毒治疗中断的患病率、趋势及危险因素

Prevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003-2015.

作者信息

Gesesew Hailay Abrha, Ward Paul, Woldemichael Kifle, Mwanri Lillian

机构信息

Public Health, Flinders University, Adelaide, Australia.

Epidemiology, Jimma University, Jimma, Ethiopia.

出版信息

PLoS One. 2017 Jun 16;12(6):e0179533. doi: 10.1371/journal.pone.0179533. eCollection 2017.

Abstract

BACKGROUND

It is well acknowledged that antiretroviral therapy (ART) discontinuation hampers the progress towards achieving the UNAIDS treatment targets that aim to treat 90% of HIV diagnosed patients and achieve viral suppression for 90% of those on treatment. Nevertheless, the magnitude, trend and risk factors for ART discontinuation have not been explored extensively. We carried out a retrospective data analysis to assess prevalence, trend and risk factors for ART discontinuation among adults in Southwest Ethiopia.

METHODS

12 years retrospective cohort analysis was performed with 4900 HIV-infected adult patients between 21 June 2003 and 15 March 2015 registered at the ART clinic at Jimma University Teaching Hospital. ART discontinuation could be loss to follow-up, defaulting and/or stopping medication while remaining in care. Because data for 2003 and 2015 were incomplete, the 10 years data were used to describe trends for ART discontinuation using a line graph. We used binary logistic regression to identify factors that were correlated with ART discontinuation. To handle missing data, we applied multiple imputations assuming missing at random pattern.

RESULTS

In total, 4900 adult patients enrolled on ART, of whom 1090 (22.3%) had discontinued, 954 (19.5%) had transferred out, 300 (6.1%) had died, 2517 (51.4%) were alive and on ART, and the remaining 39 (0.8%) had unknown outcome status. The trend of ART discontinuation showed an upward direction in the recent times and reached a peak, accounting for a magnitude of 10%, in 2004 and 2005. Being a female (AOR = 2.1, 95%CI: 1.7-2.8), having an immunological failure (AOR = 2.3, 1.9-8.2), having tuberculosis/HIV co-infection (AOR = 1.5, 1.1-2.1) and no previous history of HIV testing (AOR = 1.8, 1.4-2.9) were the risk factors for ART discontinuation.

CONCLUSIONS

One out of five adults had discontinued from ART, and the trend of ART discontinuation increased recently. Discontinued adults were more likely to be females, tuberculosis/HIV co-infected, with immunological failure and no history of HIV testing. Therefore, it is vital to implement effective programs such as community ART distribution and linkage-case-management to enhance ART linkage and retention.

摘要

背景

众所周知,抗逆转录病毒疗法(ART)的中断阻碍了实现联合国艾滋病规划署治疗目标的进程,该目标旨在治疗90%的已确诊HIV患者,并使90%接受治疗的患者实现病毒抑制。然而,ART中断的程度、趋势和风险因素尚未得到广泛研究。我们进行了一项回顾性数据分析,以评估埃塞俄比亚西南部成年人中ART中断的患病率、趋势和风险因素。

方法

对2003年6月21日至2015年3月15日在吉姆马大学教学医院抗逆转录病毒治疗诊所登记的4900名感染HIV的成年患者进行了12年的回顾性队列分析。ART中断可能是失访、违约和/或在仍接受治疗时停止用药。由于2003年和2015年的数据不完整,因此使用10年的数据通过折线图来描述ART中断的趋势。我们使用二元逻辑回归来确定与ART中断相关的因素。为处理缺失数据,我们采用多重插补法,假设数据缺失为随机模式。

结果

共有4900名成年患者开始接受抗逆转录病毒治疗,其中1090名(22.3%)已经中断治疗,954名(19.5%)已经转出,300名(6.1%)已经死亡,2517名(51.4%)仍在接受治疗且存活,其余39名(0.8%)结局状态未知。ART中断的趋势在最近呈上升趋势,并在2004年和2005年达到峰值,占比为10%。女性(调整后比值比[AOR]=2.1,95%置信区间[CI]:1.7 - 2.8)、出现免疫失败(AOR = 2.3,1.9 - 8.2)、合并结核/HIV感染(AOR = 1.5,1.1 - 2.1)以及既往无HIV检测史(AOR = 1.8,1.4 - 2.9)是ART中断的风险因素。

结论

五分之一的成年人停止了抗逆转录病毒治疗,且ART中断的趋势最近有所增加。停止治疗的成年人更有可能是女性、合并结核/HIV感染、出现免疫失败且无HIV检测史。因此,实施有效的项目,如社区抗逆转录病毒治疗分发和关联病例管理,以加强抗逆转录病毒治疗的关联和留存至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ea1/5473588/5c0d49c0005d/pone.0179533.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验